PCL-PEG-HAAM composite scaffold for promoting periodontal ligament stem cells to be differentiated into bones and preparation method of PCL-PEG-HAAM composite scaffold

PCL-PEG-HAAM composite scaffold prepared by combining HAAM with PCL-PEG electrospinned nanofiber membrane membrane membranes, the problems of insufficient mechanical properties and low biological activity of periodontal tissue regeneration materials were solved, and the periodontal membrane stem cells were significantly promoted. Proliferation and osteogenic differentiation achieve synergistic efficiency of periodontal tissue regeneration.

CN119015507APending Publication Date: 2024-11-26STOMATOLOGICAL HOSPITAL AFFILIATED TO ZUNYI MEDICAL UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411127861.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-16
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

Existing periodontal tissue regeneration materials have problems of insufficient mechanical properties and low biological activity in promoting the differentiation of periodontal stem cells into bone. In particular, the degradation rate of human decellularized amniotic membrane is too fast and the low mechanical properties limit its regeneration in bone tissue. Application in.

Method used

Using PCL-PEG-HAAM composite scaffold, lyophilized HAAM is combined with PCL-PEG electrospinned nanofiber membrane membrane, and a composite scaffold with improved mechanical properties is prepared by gelatin coating and compaction technology to promote periodontal Proliferation and osteogenic differentiation of membrane stem cells.

Benefits of technology

It improves the mechanical properties of HAAM and significantly promotes the proliferation, adhesion and osteogenic differentiation of periodontal membrane stem cells, demonstrating the synergistic effect of PCL-PEG-HAAM composite scaffold in periodontal tissue regeneration.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119015507A_ABST
    Figure CN119015507A_ABST
Patent Text Reader

Abstract

The invention relates to a PCL-PEG-HAAM composite scaffold for promoting periodontal ligament stem cells to differentiate into bones and a preparation method thereof, and relates to the technical field of periodontal tissue regeneration materials, the preparation method comprises the following steps: obtaining freeze-dried HAAM; the PCL-PEG electrostatic spinning nanofiber membrane is obtained; the surface of the PCL-PEG electrostatic spinning nanofiber membrane is coated with gelatin, and a first PCL-PEG electrostatic spinning nanofiber membrane is obtained; and spreading the freeze-dried HAAM on the surface of the first PCL-PEG electrostatic spinning nanofiber membrane, and the like. According to the preparation method, the HAAM and the PCL-PEG electrostatic spinning nanofiber membrane are jointly prepared for the first time to obtain the PCL-PEG-HAAM composite scaffold, the advantages and disadvantages of the HAAM and the PCL-PEG electrostatic spinning nanofiber membrane are complemented, and the defects of a single HAAM or single PCL-PEG electrostatic spinning nanofiber membrane are overcome.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of periodontal tissue regeneration materials, and in particular to a PCL-PEG-HAAM composite scaffold for promoting the differentiation of periodontal ligament stem cells into bones and a preparation method thereof. Background Art

[0002] Periodontal ligament stem cells (PDLSCs) are a type of dental mesenchymal stem cells that exist in the periodontal ligament. They have high self-renewal ability and multi-lineage differentiation potential. PDLSCs play a vital role in maintaining periodontal homeostasis. Under appropriate in vitro induction conditions, PDLSCs can differentiate into different cell lineages, such as osteoblasts, adipocytes, and chondroblasts. Among various mesenchymal stem cells used for periodontal regeneration, PDLSCs have been shown to form new cementum-like structures in vivo. In addition, PDLSCs are rich in sources, easy to obtain, and involve less medical ethics, making them important seed cell candidates in periodontal tissue regeneration research.

[0003] In recent years, biodegradable synthetic polymer materials have been widely used in the regeneration of blood vessels, bones, periodontal tissues, etc. due to their low price, scalable production, low toxicity, and the ability to flexibly control and fine-tune the properties of the scaffold through chemical modification. Among them, the slow degradation of polycaprolactone (PCL) provides sufficient time for bone tissue regeneration and does not produce an overly acidic environment in the body, making it one of the most widely used polymers in bone tissue regeneration; Polyethylene glycol (PEG) is one of the most commonly used biocompatible modifiers in polymers, with good hydrophilicity, biocompatibility, and no rejection reaction. Its appropriate addition can be used to enhance the hydrophilicity of the material surface. Therefore, electrospun nanofibers made of PCL with PEG added are expected to be more hydrophilic and friendly to cells without toxicity or degradation burden. However, compared with natural extracellular matrix, they lack the natural active functional sites of cells, have lower biological activity, and increase the rejection rate in the body, and usually cannot achieve the ideal bone regeneration effect.

[0004] Human amniotic membrane (HAM) is a translucent film with a thickness of about 0.02-0.5 mm, which is composed of a single layer of human amniotic epithelium, basement membrane and avascular matrix layer. It secretes a variety of growth factors, cytokines and extracellular matrix proteins, and has the advantages of anti-inflammatory, antibacterial and anti-fibrosis. HAM has been widely used in the repair of ocular and skin trauma. In addition, studies have shown that HAM can promote bone regeneration. However, the presence of cells limits the use of HAM, such as graft rejection, storage difficulties, and a short shelf life. To overcome this problem, HAM is decellularized to retain the natural extracellular matrix, whose main components include collagen, laminin, fibronectin, elastin, hyaluronic acid, fibroblast growth factor, and transforming growth factor. This not only retains its original function but also reduces immunogenicity. In theory, compared with HAM, human acellular amniotic membrane (HAAM) is a safer and more effective scaffold material. It can be used as an extracellular matrix to load cells to construct engineered tissues and organs. It can also play a role in the delivery of cytokines or growth factors, providing controlled release of these substances to promote healing and regeneration. However, it is limited in bone tissue regeneration due to its rapid degradation rate and low mechanical properties.

[0005] The strategy of tissue regeneration is to manufacture biocompatible, safe, non-toxic and bioactive materials to promote periodontal tissue regeneration. At present, biomimetic composite materials that combine the excellent mechanical properties of synthetic polymers with the bioactivity of natural extracellular matrix have attracted attention in tissue regeneration, but there are no related research reports on the combined application of HAAM and PCL-PEG electrospun nanofiber membranes in the osteogenic differentiation of PDLSCs in the prior art. Summary of the invention

[0006] In order to solve the above problems, the present invention provides a PCL-PEG-HAAM composite scaffold for promoting the differentiation of periodontal ligament stem cells into bone and a preparation method thereof.

[0007] In a first aspect, the present invention provides a method for preparing a PCL-PEG-HAAM composite scaffold for promoting the differentiation of periodontal ligament stem cells into bone, the preparation method comprising the following steps:

[0008] Freeze-dried HAAM was obtained;

[0009] The PCL-PEG electrospun nanofiber membrane was obtained;

[0010] Coating gelatin on the surface of the PCL-PEG electrospun nanofiber membrane to obtain a first PCL-PEG electrospun nanofiber membrane;

[0011] The freeze-dried HAAM is spread on the surface of the first PCL-PEG electrospun nanofiber membrane and then compacted to obtain the PCL-PEG-HAAM composite scaffold.

[0012] Furthermore, in terms of weight percentage, the coating amount of the gelatin accounts for 0.1% of the weight of the PCL-PEG electrospun nanofiber membrane.

[0013] Furthermore, the PCL-PEG electrospun nanofiber membrane and the HAAM have the same size; the size is 4 cm×4 cm.

[0014] Furthermore, the compaction process is as follows: using a roller to apply pressure to tightly adhere PCL-PEG and HAAM together, removing air bubbles between the two, and placing them in a clean room to dry overnight.

[0015] Furthermore, the step of obtaining freeze-dried HAAM includes the following process:

[0016] Get HAM;

[0017] The HAM was rinsed with PBS, and then immersed in PBS containing 2wt% of the triple antibody for 30 minutes, and the fresh HAM was placed in a 50mL centrifuge tube containing 5wt% Triton X-100 solution, and the added 5wt% Triton X-100 solution was twice the volume of the tissue, and the HAM was placed in an air bath constant temperature water bath at 37°C for 1 hour of shaking, and then rinsed with PBS solution for 4-5 times after being taken out, and then added to a centrifuge tube containing 0.25wt% trypsin, and placed in an air bath constant temperature water bath at 37°C for 1 hour of shaking, and the volume of trypsin was twice the volume of the tissue, and then rinsed with PBS solution for 4-5 times after being taken out, and then the amniotic epithelial surface was gently scraped with a cell scraper, and then rinsed with PBS solution for 4-5 times after scraping to remove residual cells to obtain the HAAM;

[0018] The HAAM was placed in a sterile curved dish for trimming, with the amniotic epithelial layer facing upward, and placed in a 10 cm culture dish, placed in a -80°C refrigerator overnight, and freeze-dried on the second day for 8 hours to obtain the freeze-dried HAAM.

[0019] Furthermore, the step of obtaining the PCL-PEG electrospinning nanofiber membrane includes the following process:

[0020] Electrospinning nanofibers were prepared using an electrospinning machine. 0.9 g PCL and 0.1 g PEG were weighed on a balance and poured into 8 mL of a solvent consisting of alcohol and hexafluoroisopropanol in a volume ratio of 1:4. The solvent was placed on a magnetic stirrer and stirred for 16 h at room temperature. The syringe was then completely sucked into a 10 mL syringe and fixed on the electrospinning machine. The receiving distance was set to 20 cm, the voltage to 7 kV, and the propulsion speed to 0.8 mL / h. The syringe was collected on aluminum foil to obtain a PCL-PEG electrospun nanofiber membrane. The fiber membrane was placed in a 37 °C oven and dried for 48 hours to remove the solvent and stored for later use.

[0021] Furthermore, the thickness of the PCL-PEG electrospun nanofiber membrane is 140-160 μm.

[0022] Furthermore, the thickness of the HAAM is 35-50 μm.

[0023] In a second aspect, the present invention provides a PCL-PEG-HAAM composite scaffold for promoting the differentiation of periodontal ligament stem cells into bone, wherein the PCL-PEG-HAAM composite scaffold for promoting the differentiation of periodontal ligament stem cells into bone is prepared by the preparation method described in any one of the first aspects.

[0024] The above technical solution provided by the embodiment of the present invention has at least the following advantages compared with the prior art:

[0025] The embodiment of the present invention provides a PCL-PEG-HAAM composite scaffold that promotes the differentiation of periodontal ligament stem cells into bone and a preparation method thereof. The present invention combines HAAM with PCL-PEG electrospun nanofiber membrane for the first time to prepare a polycaprolactone-polyethylene glycol-human acellular amniotic membrane (PCL-PEG-HAAM) composite scaffold, and further explores its physical properties and its effects on the proliferation, adhesion and osteogenic differentiation of periodontal ligament stem cells. The main results are as follows:

[0026] 1) HE staining showed that the amniotic epithelial cells and mesenchymal cells were removed and the basal layer and dense layer of HAM were completely retained. Scanning electron microscopy showed that the surface of the basement membrane was intact without peeling, and the dense layer showed collagen fibers of different diameters interwoven to form a porous spider web structure. Scanning electron microscopy showed that the composite scaffold was a double-layer membrane structure with an obvious boundary line between the two. HAAM was tightly connected to the "fishing net-like" PCL-PEG nanofibers below. The mechanical properties of the PCL-PEG-HAAM composite scaffold were better than those of HAAM.

[0027] 2) CCK-8 results showed that the cell proliferation rate in the PCL-PEG-HAAM group was the highest; the cell adhesion rate in the PCL-PEG-HAAM group was higher than that in the PCL-PEG group and the HAAM group (P<0.05).

[0028] 3) BCIP / NBT staining and Alizarin red staining results showed that PCL-PEG, HAAM, and PCL-PEG-HAAM scaffolds could promote the osteogenic differentiation of PDLSCs. Among them, the staining area of ​​PCL-PEG-HAAM group was the deepest and widest. WB results showed that the expression levels of RUNX2, COL1, and ALP osteogenic proteins in PCL-PEG-HAAM group were significantly higher than those in blank control group and PCL-PEG group (P<0.05).

[0029] In summary, the PCL-PEG-HAAM composite scaffold prepared by combining HAAM and PCL-PEG electrospun nanofiber membrane provided by the present invention not only improves the mechanical properties of HAAM, but also promotes the proliferation, adhesion and osteogenic differentiation of PDLSCs. The combined use of HAAM and PCL-PEG electrospun nanofiber membrane shows significant synergistic effect, providing a new biomaterial for promoting osteogenic differentiation of PDLSCs. BRIEF DESCRIPTION OF THE DRAWINGS

[0030] The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate embodiments consistent with the invention and, together with the description, serve to explain the principles of the invention.

[0031] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, for ordinary technicians in this field, other drawings can be obtained based on these drawings without paying any creative labor.

[0032] Figure 1 This is a scanning electron microscope image of the HAAM obtained in Example 2.

[0033] Figure 2 The macroscopic and microscopic structures of the PCL-PEG-HAAM composite scaffold of the present invention.

[0034] Figure 3 Figure 2 shows the mechanical properties test results of PCL-PEG-HAAM composite scaffold, HAAM and PCL-PEG.

[0035] Figure 4 This is the result of CCK-8 detection of the effects of PCL-PEG-HAAM composite scaffold, HAAM and PCL-PEG on the proliferation of PDLSCs.

[0036] Figure 5 This is a graph showing the effects of PCL-PEG-HAAM composite scaffold, HAAM and PCL-PEG on PDLSCs adhesion.

[0037] Figure 6 These are the BCIP / NBT staining results of PCL-PEG-HAAM composite scaffolds, HAAM and PCL-PEG.

[0038] Figure 7 These are the results of Alizarin red staining of PCL-PEG-HAAM composite scaffold, HAAM and PCL-PEG.

[0039] Figure 8 The graph shows the expression results of osteogenic-related proteins in PCL-PEG-HAAM composite scaffolds, HAAM and PCL-PEG after 7 days.

[0040] Fig. 9 This is the quantitative analysis result of the grayscale value of osteogenic-related proteins in PCL-PEG-HAAM composite scaffold, HAAM and PCL-PEG. DETAILED DESCRIPTION

[0041] In order to make the purpose, technical solution and advantages of the embodiments of the present invention clearer, the technical solution in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0042] Unless otherwise specified, various raw materials, reagents, instruments and equipment used in the present invention can be purchased from the market or prepared by existing methods.

[0043] The present invention will be further described below in conjunction with specific examples. It should be understood that these examples are intended only to illustrate the present invention and are not intended to limit the scope of the present invention. The experimental methods in the following examples that do not specify specific conditions are usually measured according to national standards. If there is no corresponding national standard, then the conditions recommended by the manufacturer are followed.

[0044] The main English abbreviations involved in the present invention are explained in Table 1 below:

[0045] Table 1

[0046]

[0047]

[0048] Example 1

[0049] This example provides a method for preparing freeze-dried HAAM, comprising the following steps:

[0050] 1) Primary culture of PDLSCs:

[0051] First and second premolars or ectopic third molars with healthy periodontium and complete root development who were under 25 years old and required orthodontic extraction were selected from the Department of Oral and Maxillofacial Surgery, Affiliated Stomatological Hospital of Zunyi Medical University (approved by the hospital ethics committee). The collected ex vivo teeth were repeatedly rinsed with 0.9% normal saline, placed in a 15 mL centrifuge tube (α-MEM containing a mixture of 2% penicillin-streptomycin-amphotericin B), and transferred to the laboratory in time. The ex vivo teeth were repeatedly rinsed with PBS containing a mixture of 1% penicillin-streptomycin (Note: the teeth were inverted during rinsing and rinsed from the root to the crown), and then transferred to a 10 cm culture dish (3 mL PBS was added to keep the periodontal ligament moist), and 1 / 3 of the periodontal ligament tissue in the root was scraped with a sterile scalpel. The collected periodontal ligament tissue was transferred to a 15 mL centrifuge tube, centrifuged for 5 min (800 rpm / min), the supernatant was discarded, and 1 mL Dilute type I collagenase, pipette gently for 30 seconds to mix, then digest for 40 minutes in a constant temperature shaking water bath at 37°C, terminate digestion with 2 volumes of 10% complete medium, centrifuge for 5 minutes (800rpm / min), discard the supernatant, add 3mL of 20% complete medium, pipette to resuspend the tissue blocks, then transfer to a T25 culture flask, place in a 5% CO2, 37°C constant temperature incubator for culture, and change the medium every 3 days.

[0052] 2) Subculture of PDLSCs:

[0053] Take out the T25 culture flask from the incubator and observe the cell growth under a microscope. When the cells grow to 90% of the bottom plate of the culture flask, rinse with PBS three times, add 1mL of 0.25% trypsin and digest in a 5% CO2, 37℃ incubator for 1min (digestion time should not exceed 2min). Observe the cell morphology under a microscope. Most of the cells shrink, become round and fall off. Tap the bottom of the flask to make the cells completely detach from the culture flask. Add 2mL of 10% complete medium to terminate the digestion. Centrifuge for 5min (800rpm / min), discard the supernatant, add 3mL of complete medium to resuspend, and distribute into 1 T75 or 3 T25 culture flasks, place in a 5% CO2, 37℃ constant temperature incubator for culture, and change the medium every 3 days.

[0054] 3) Flow cytometry identification of PDLSCs:

[0055] The third generation PDLSCs were taken, the stock solution was discarded, and PBS was used to rinse three times. 0.25% trypsin was added to digest for 2 min at room temperature, and then 2 times the volume of complete medium was added to terminate the digestion. The cell suspension was collected and centrifuged for 5 min (1200 rpm / min). The supernatant was removed, the precipitate was washed with PBS, and centrifuged again. PBS was added to adjust the cell concentration to 2×10 5 / mL, add 100μL of cell suspension to 5 marked flow tubes respectively, add mouse anti-human monoclonal antibodies: CD90, CD73, CD44, CD105 and negative control mixture CD19 / CD34 / CD11b / CD45 / HLADR to the marked flow tubes, oscillate to mix, incubate for 30min in dark conditions, add 2mL of flow washing buffer, oscillate to mix, centrifuge for 5min (1200rpm / min), discard the supernatant, add 300μL of flow washing buffer to resuspend, pass through a 200-mesh filter and then detect on the machine.

[0056] 4) Detection of the differentiation potential of PDLSCs into osteoblasts, chondrocytes and adipocytes:

[0057] (1) Inducing differentiation into osteoblasts: PDLSCs of generation P3 were taken and the cell density was adjusted to 1.0×10 5 / mL, and inoculate 1mL into a 12-well plate, transfer to an incubator for continued culture, and when the cells grow to 80%-90% of the bottom area of ​​the 12-well plate, discard the original culture medium, wash with sterile PBS three times, add osteogenic induction culture medium (change the medium every 3 days, and change the medium gently), after continuous induction for 21 days, discard the original solution, rinse with sterile PBS 3 times, fix with 4% paraformaldehyde for 30 minutes, rinse with PBS three times, add 1mL of Alizarin Red stain to each well, stain for 10 minutes, wash with PBS three times, observe and photograph under an inverted microscope.

[0058] (2) Inducing differentiation into chondrocytes: P3 generation PDLSCs were taken and the cell density was adjusted to 1.0×10 5 / mL, and inoculate 1mL into a 12-well plate, transfer to an incubator for continued culture, and when the cells grow to 80%-90% of the bottom of the 12-well plate, discard the original culture medium, wash with sterile PBS for 3 times, add chondrogenic induction culture medium (change the medium every 3 days, and change the medium gently). After 21 consecutive days of induction, discard the original culture medium, rinse with sterile PBS for 3 times, fix with 4% paraformaldehyde for 30 minutes, rinse with PBS for 3 times, add 1mL of Alcian blue staining solution to each well for 30 minutes, rinse with PBS for 3 times, wash with Alcian acidification working solution for 1 minute, observe and photograph under an inverted microscope.

[0059] (3) Inducing differentiation into adipocytes: PDLSCs of generation P3 were taken and the cell density was adjusted to 1.0×10 5 / mL, and inoculate 1mL into a 12-well plate, transfer to an incubator for continued culture, and when the cells grow to 80%-90% of the bottom of the 24-well plate, discard the original culture medium, wash with sterile PBS three times, add adipogenic induction culture medium, and induce for 21 consecutive days, then discard the original solution, rinse with sterile PBS three times, fix with 4% paraformaldehyde for 30 minutes, add 1mL Oil Red O staining solution (saturated Oil Red O staining: distilled water = 3:2, mix well and filter with 0.22μm filter), stain for 30 minutes, rinse with PBS three times, observe under an inverted microscope and take pictures.

[0060] The results show that:

[0061] 1. Primary culture and passaging of PDLSCs: On the 7th day of culture using the enzyme digestion method, primary periodontal ligament cells were seen crawling out from the edge of the tissue block in a triangular, polygonal or irregular shape. Around the 12th day, a large number of PDLSCs were seen crawling out, covering about 90% of the bottom plate area. The cells were in good condition and grew in a whorl shape. After passaging to the P3 generation, the cell morphology of PDLSCs was long fusiform and spindle-shaped, showing a typical mesenchymal stem cell morphology.

[0062] 2. Flow cytometric detection of PDLSCs-related phenotypic molecules: Flow cytometric detection showed that the surface antigens CD90 (99.4%), CD73 (99.9%), CD105 (95.3%), and CD44 (99.8%) of PDLSCs were highly expressed, and CD45 / CD11b / CD19 / CD34 / HLADR (0.32%) were lowly expressed, which met the definition of mesenchymal stem cells.

[0063] 3. Detection of osteogenic, adipogenic and chondrogenic differentiation of PDLSCs: After 21 days of induction with osteogenic, adipogenic and chondrogenic induction medium, the three-lineage differentiation potential of PDLSCs was identified by Alizarin Red, Oil Red O and Orexin Blue staining, respectively. The results showed that Alizarin Red staining showed scattered irregular red calcified nodules; Oil Red O staining showed that the cell cytoplasm was rich in orange-red lipid droplets; Orexin Blue staining showed scattered large areas of blue-stained masses.

[0064] Example 2

[0065] This example provides a method for preparing HAAM by mechanical / chemical / enzymatic digestion, including the following process:

[0066] 1) Acquisition of HAM:

[0067] Obtained from the Department of Obstetrics, Affiliated Hospital of Zunyi Medical University (this study was reviewed by the Medical Ethics Committee of the Affiliated Stomatological Hospital of Zunyi Medical University, and the pregnant women gave informed consent and met the relevant ethical requirements), full-term pregnant women aged 20-35 years who underwent cesarean section were selected, and prenatal serological examinations excluded infectious diseases such as AIDS, hepatitis B, and syphilis. Prepare a sterile instrument box, find the connection between HAM and chorion, and use surgical scissors, surgical forceps, and vascular clamps for blunt dissection. During the dissection process, PBS was continuously used for flushing to rinse the blood clots mixed with HAM, put it in a 50mL centrifuge tube containing sterile PBS containing 2% tertiary antibody, and immediately transfer it to the laboratory.

[0068] 2) Preparation of HAAM:

[0069] After being transferred to the laboratory, the HAM was rinsed with PBS three times in the clean bench to remove excess blood and mucus from the surface of the HAM. It was then soaked in PBS containing 2% triple antibody for 30 minutes. The fresh HAM was placed in a 50mL centrifuge tube containing 5% Triton X-100 solution. The added 5% Triton X-100 solution was twice the volume of the tissue. The HAM was placed in an air bath constant temperature water bath and oscillated at 37°C for 1 hour. After being taken out, it was rinsed with a large amount of PBS solution for 4-5 times. Then, it was added to a 50mL centrifuge tube containing 0.25% trypsin and placed in an air bath constant temperature water bath for oscillation at 37°C for 1 hour. The volume of trypsin was twice the volume of the tissue. After being taken out, it was rinsed with PBS solution for 4-5 times. Then, a cell scraper was used to gently scrape the amniotic epithelial surface. After scraping, it was rinsed with PBS solution for 4-5 times to remove residual cells. Place HAAM in a sterile curved dish and trim it into a size of 4 cm × 4 cm, with the amniotic epithelial layer facing upwards, place it in a 10 cm culture dish, place it in a -80°C refrigerator overnight, and freeze-dry it on the second day for 8 hours.

[0070] 3) Decellularization and surface characteristics of HAAM:

[0071] (1) HE staining was used to detect whether HAM was completely decellularized. HAM and HAAM were fixed with 4% paraformaldehyde for 30 min, rinsed twice with pure water, embedded in paraffin and sectioned in the usual way; xylene (I) for 4 min → xylene (II) for 4 min → anhydrous ethanol for 2 min → 95% ethanol for 2 min → 70% ethanol for 1 min → 50% ethanol for 1 min → immersion in tap water for 5 min → hematoxylin staining for 10 min → immersion in tap water for 5-10 s → 1% hydrochloric acid alcohol decolorization for 0.5 s → immersion in warm water for 10 min → eosin staining for 2 min → rinsing with tap water for 5-10 s → drying for 8 min → sealing the slides and observing under an upright microscope.

[0072] (2) Observation of the surface characteristics of HAAM under a scanning electron microscope: After gold was sprayed on the surface of HAAM, the microstructure was observed using a scanning electron microscope.

[0073] The results show that:

[0074] 1. Preparation of HAAM by mechanical / chemical / enzymatic digestion method: HAAM prepared by mechanical / chemical / enzymatic digestion method is a white translucent film. HAAM prepared by 8h freeze-drying is a white wrinkled paper with a rough and non-smooth surface.

[0075] 2. HE staining of HAAM: Normal HAM is composed of an amniotic epithelial cell layer, a basement membrane, and a matrix layer containing amniotic mesenchymal cells; HAAM can be seen by removing the amniotic epithelial cells and mesenchymal cells and completely retaining the basal layer and dense layer of HAM.

[0076] 3. Surface morphology of HAAM: HAAM basal layer and dense layer. It can be seen that the surface of the basal layer is smooth and compact, with no obvious cracks or peeling surfaces. In the dense layer, fibers of different diameters are interwoven into a network, with clear fiber morphology and no obvious dissolution and fracture. Figure 1 As shown, Figure 1 Scanning electron microscopy images of HAAM (scale bars: A: 10 μm; B: 5 μm; C: 5 μm; D: 2 μm), A / B: basal layer of HAAM; C / D: dense layer of HAAM.

[0077] Example 3

[0078] This example provides a PCL-PEG electrospun nanofiber membrane, and the preparation method thereof includes the following steps:

[0079] Electrospinning nanofibers were prepared using an electrospinning machine. 0.9 g PCL and 0.1 g PEG were weighed on a balance and poured into 8 mL of solvent (alcohol: hexafluoroisopropanol = 1:4). The solvent was placed on a magnetic stirrer and stirred for 16 h at room temperature. The syringe was then completely sucked into a 10 mL syringe and fixed on the electrospinning machine. The receiving distance was set to 20 cm, the voltage was 7 kV, and the propulsion speed was 0.8 mL / h. The syringe was collected on aluminum foil to obtain PCL-PEG electrospun nanofiber membranes. The fiber membranes were dried in an oven at 37 °C for 48 hours to remove the solvent and stored for later use.

[0080] Example 4

[0081] This example provides a PCL-PEG-HAAM composite scaffold, the preparation method of which includes the following process:

[0082] The PCL-PEG electrospun nanofiber membrane obtained in Example 3 and the freeze-dried HAAM obtained in Example 2 were trimmed into large-area films of about 4 cm × 4 cm, 0.1% gelatin was coated on the surface of PCL-PEG, and the freeze-dried HAAM was spread on it (with the basement membrane facing up), compacted, air-dried overnight in a clean bench, and stored in a -20°C refrigerator. The morphology of the scaffold could be observed through a scanning electron microscopy cross-section.

[0083] Test Case

[0084] In this example, the PCL-PEG electrospun nanofiber membrane, HAAM, and PCL-PEG-HAAM composite scaffold obtained in the above examples were subjected to performance tests.

[0085] 1) Mechanical property determination: A universal mechanical measuring instrument was used to perform mechanical tests on the PCL-PEG electrospun nanofiber membrane, HAAM, and PCL-PEG-HAAM composite scaffold. The fiber membrane scaffold was cut into a size of 20.0 mm × 10.0 mm and fixed on the universal mechanical measuring instrument. The sample was stretched with a constant tensile force of 50 N until the sample broke, and parameters such as the tensile strength of the scaffold and the maximum load were obtained.

[0086] 2) Detect the cell proliferation ability of PCL-PEG-HAAM composite scaffolds by CCK-8: Before the experiment, the PCL-PEG electrospun nanofiber membrane needs to be sterilized and placed in a formaldehyde fumigation box for 24 hours, and then placed in a clean bench for 3 days to volatilize the residual formaldehyde on the electrospun membrane. According to the experimental needs, the nanofiber membrane is prepared to the size of the corresponding well plate bottom plate, and the fiber membrane is fixed with a sterile steel ring. 200μL-1mL 10% complete culture medium is added and soaked for 1 hour to completely wet the fiber membrane. The culture medium is discarded when used. The experimental groups are: blank control group (control group); PCL-PEG group; HAAM group; PCL-PEG-HAAM group. PDLSCs of the P3 generation were taken and counted, and the concentration was adjusted to 2×10 4 / mL, inoculate 200 μL of cell suspension in 48-well plates, set 3 replicates in each group, and inoculate 4 48-well plates in total, transfer to 37°C, 5% CO2 incubator, take out and replace the culture medium every 3 days, take out a 48-well plate at the same time point on the 1st, 3rd, 5th and 7th days, discard the culture medium, rinse with PBS 3 times, add 20 μL CCK-8 solution and 180 μL 10% complete culture medium to each well, put it in a constant temperature incubator and incubate it in the dark for 2 hours, aspirate 100 μL of liquid from each well and transfer it to a 96-well plate, measure the OD value at 450nm with an enzyme marker, measure on the 1st, 3rd, 5th and 7th days in the same way, and make a cell growth curve with OD value as the ordinate and time (d) as the abscissa.

[0087] 3) Adhesion ability of PCL-PEG-HAAM composite scaffolds: PDLSCs of generation P3 were taken and counted, and the cell density was adjusted to 1.0×10 5 / mL, take 1mL of cell suspension and inoculate on PCL-PEG, HAAM, PCL-PEG-HAAM membrane (24-well plate), 3 replicates, culture for 4h, discard the medium, rinse 3 times with PBS, add 500μL 0.25% trypsin to digest the cells on the scaffold, digestion time is 2min, tap the bottom of the well plate, 2 times 10% complete medium to terminate digestion, use a pipette to blow repeatedly, collect single cell suspension, centrifuge for 5min (1000rpm / min), discard the supernatant, resuspend in 1mL10% complete medium, and count. Calculate the cell adhesion rate of each group according to cell adhesion rate = number of cells after digestion / initial inoculation number of cells × 100%.

[0088] 4) Detection of the effect of PCL-PEG-HAAM composite scaffold on osteogenic differentiation of PDLSC: (1) BCIP / NBT staining experiment: The experimental groups were: blank control group (control group); PCL-PEG group; HAAM group; PCL-PEG-HAAM group. PDLSCs of generation P3 were taken and the cell density was adjusted to 1.0×10 5 / mL, and inoculate 1mL into a 12-well plate, transfer to an incubator for continued culture, and when the cells grow to 80%-90% of the bottom of the 12-well plate, discard the culture medium, wash with sterile PBS for 3 times, add osteogenic induction culture medium (change the medium every 3 days), wash with PBS for 3 times, fix with 4% paraformaldehyde for 30 minutes, and rinse with PBS for 3 times (be careful not to rinse too hard, otherwise it will easily peel off the membrane), prepare the stain according to the instructions, add 1mL of stain to each well, incubate at room temperature for 30 minutes, rinse with pure water, and observe under an inverted microscope.

[0089] (2) Alizarin red staining: The experimental groups were: blank control group (control group); PCL-PEG group; HAAM group; PCL-PEG-HAAM group. PDLSCs of generation P3 were taken and the cell density was adjusted to 1.0×10 5 / mL, and inoculate 1mL into a 12-well plate, transfer to an incubator for continued culture, and when the cells grow to 80%-90% of the bottom of the 12-well plate, discard the original culture medium, wash 3 times with sterile PBS, add osteogenic induction culture medium (change the medium every 3 days), wash 3 times with PBS, fix with 4% paraformaldehyde for 30 minutes, and rinse 3 times with PBS (be careful not to rinse too hard, otherwise it will easily peel off the membrane), add 1mL of Alizarin Red reagent to each well, stain for 10 minutes, rinse with pure water, and observe under an inverted microscope.

[0090] 5) Western blot detection of osteogenic related proteins: The experimental groups were: blank control group (control group); PCL-PEG group; HAAM group; PCL-PEG-HAAM group. PDLSCs of generation P3 were taken and the cell density was adjusted to 1.0×10 5 2 mL of the solution was inoculated into a 6-well plate and transferred to a 37°C constant temperature incubator for culture. When the cells grew to 80% of the bottom area of ​​the well, the original solution was discarded and the cells were rinsed 3 times with PBS. The osteogenic induction solution was added to the blank control group and the experimental group, and the solution was replaced every 3 days. After 7 days of continuous induction, the osteogenic-related proteins ALP, COL1, and RUNX2 were detected.

[0091] (1) Total cell protein extraction: discard the stock solution, rinse three times with PBS, add 100 μL of protein lysis mixture (RIPA: PMSF: protein phosphatase inhibitor = 100:1:1, prepared before use) to each well, lyse on ice for 10 min, scrape the incompletely lysed cells on the bottom of the well plate with a cell scraper, mix by pipetting, transfer to a labeled 1.5 mL EP tube, centrifuge at 4°C, 12,000 rpm for 5 min, discard the precipitate, aspirate the supernatant and transfer to a new pre-cooled 1.5 mL EP tube, mark it, determine the protein concentration (BCA method), calculate the liquid volume required for each group, add PBS and protein loading buffer, mix well, boil at 100°C for 10-15 min, and store at -80°C for use to avoid repeated freezing and thawing. BCA protein quantification: BCA protein quantification kit was used for detection. The protein standard preparation solution (concentration of 5 mg / mL) was diluted 10 times with PBS to obtain a protein standard solution with a concentration of 0.5 mg / mL for standby use. BCA reagent: Cu reagent = 50:1 to prepare BCA working solution (prepared before use). A standard curve group and a sample group were set up respectively. The concentrations of protein standards diluted with PBS were: 0, 0.025, 0.05, 0.1, 0.2, 0.3, 0.4, and 0.5 mg / mL. 20 μL of the protein standards of the above dilution concentrations were taken from the standard curve group and added to a 96-well plate, with 3 replicates for each dilution concentration. 20 μL of the sample to be tested after 20-fold dilution was added to the sample group, with 3 replicates for each concentration. 200 μL of BCA working solution was added to each well of the standard curve group and the sample group, and the plates were incubated in a 37°C oven away from light for 30 min. After the incubation, the absorbance was measured at a wavelength of 562 nm on an ELISA reader, and the protein concentration was calculated based on the absorbance.

[0092] (2) Glue preparation: Install the gel preparation rack, place the gel pad, fix the glass plate on the gel preparation rack (check the tightness before use), inject the prepared separation gel into the glass plate sandwich with a pipette (leave space for concentrated gel), add 1 mL of isopropanol to flatten the liquid surface, and after about 5-10 minutes, when the refraction line is formed, pour out the isopropanol, and then use filter paper to absorb the remaining isopropanol (do not touch the lower layer of separation gel); then inject the prepared concentrated gel into the glass plate sandwich with a pipette, insert a comb, and wait for it to solidify.

[0093] (3) Sample loading: Carefully place the gel plate into the electrophoresis tank, add the newly prepared electrophoresis solution, carefully remove the comb, and inject 2.5 μL of marker and 10 μL of each group of protein samples.

[0094] (4) Electrophoresis: Turn on the power supply, pay attention to the positive and negative poles, add electrophoresis solution into the electrophoresis pool, immerse the gel rack, and perform electrophoresis at a voltage of 80V for about 30 minutes. After the markers are separated, increase the voltage to 120V and continue electrophoresis for about 60 minutes until the bromophenol blue approaches the bottom of the glass plate.

[0095] (5) Transfer: Cut the PVDF membrane to the required size, soak it in methanol for 5 min to activate it, place it in the electrotransfer solution for later use, and place it into the electrotransfer box in the order of filter paper-PVDF membrane-gel-filter paper from bottom to top, and press it lightly with a roller to remove bubbles. Seal the box and start electrotransfer at 25 V and 2.5 A.

[0096] (6) Washing the PVDF membrane: After electroporation, remove the PVDF membrane and wash it in TBST solution three times, each time for 10 min.

[0097] (7) Blocking: Place the PVDF membrane in a pre-prepared milk blocking solution (5% skim milk powder prepared in TBST) and block on a shaker for 2 h. Rinse with TBST solution three times, 10 min each time.

[0098] (8) Incubation with primary antibody: Trim the PVDF membrane according to the molecular weight of the protein and place it in a container containing the primary antibody. Incubate it in a refrigerator at 4°C overnight. Remove the PVDF membrane and wash it three times in TBST solution for 10 min each time.

[0099] (9) Incubation with secondary antibody: Incubate the PVDF membrane in secondary antibody dilution solution for 60 min, and then wash it three times in TBST solution for 10 min each time.

[0100] (10) Exposure: Pipette solution A and solution B (volume ratio of 1:1) into a light-proof tube and mix thoroughly to prepare ECL luminescent solution. Use filter paper to absorb excess water on the surface of the PVDF membrane, evenly add exposure solution, expose the membrane to image and analyze.

[0101] The experimental data were analyzed and processed by SPSS29.0 and GraphPad Prism9.5.0 software. The results were expressed as mean ± standard deviation. The independent sample t test was used for comparison between two groups; the one-way analysis of variance was used for comparison between three groups or more; the test level was α = 0.05, and it was statistically significant when P < 0.05. The test results are as follows:

[0102] 1. Macro and micro structures of PCL-PEG-HAAM composite scaffolds: Figure 2 As shown, Figure 2 Middle: A: physical image; B / C: scanning electron microscope images (scale bars: B: 20 ​​μm; C: 10 μm). Figure 2 A shows a physical picture of the PCL-PEG-HAAM composite scaffold. It can be seen that HAAM and PCL-PEG are tightly bonded without loosening. The red arrow points to HAAM, and the blue arrow points to PCL-PEG. The cross-sectional micrograph of the scanning electron microscope ( Figure 2 B. Figure 2 C) It can be clearly seen that the composite scaffold is a double-layer membrane structure with a clear boundary line in the middle. The upper part is HAAM, and the lower part is a disordered, porous PCL-PEG nanofiber membrane. They are tightly connected without obvious warping.

[0103] 2. Mechanical properties of PCL-PEG-HAAM composite scaffolds: Figure 3 As shown, Figure 3 Middle: A: Maximum force test results; B: Tensile strength test results. The tensile strength and maximum force of HAAM were the lowest; the tensile strength and maximum force of PCL-PEG were significantly higher than those of HAAM (P<0.05), and the PCL-PEG-HAAM composite scaffold increased the tensile strength and maximum force of HAAM (P<0.05). It can be seen that the combination of HAAM and PCL-PEG can improve the mechanical properties of HAAM, and the combination of the two shows a significant synergistic effect.

[0104] 3. CCK-8 detection of the effect of PCL-PEG-HAAM composite scaffold on the proliferation of PDLSCs: Figure 4 As shown in the figure, there was no significant difference in OD values ​​among the blank control group, PCL-PEG group, HAAM group, and PCL-PEG-HAAM group on the 1st and 3rd days, and the cell proliferation rate had the same trend. However, on the 5th and 7th days, the cell proliferation rate in the PCL-PEG-HAAM group was higher than that in the blank control group and PCL-PEG group, indicating that the PCL-PEG-HAAM scaffold is conducive to cell proliferation and has no adverse effect on cells when gelatin is used as an adhesion medium.

[0105] 4. Detect the effect of PCL-PEG-HAAM scaffold on PDLSCs adhesion: Figure 5 As shown, the cell adhesion rates in the HAAM group and PCL-PEG-HAAM group were significantly higher than those in the PCL-PEG group at 4 h and the difference was statistically significant (P<0.05).

[0106] 5. BCIP / NBT staining: Figure 6 As shown, Figure 6 Middle: BCIP / NBT staining (scale: 200μm), A: control group; B: PCL-PEG group; C: HAAM group; D: PCL-PEG-HAAM group. 7 days after osteogenic induction, BCIP / NBT staining showed that the PCL-PEG-HAAM group had the deepest staining and the widest staining area, followed by the HAAM group and the PCL-PEG group, and the blank control group had the shallowest staining depth and the smallest staining area.

[0107] 6. Alizarin red staining: Figure 7 As shown, Figure 7 Middle: Alizarin red staining (scale: 200μm); A: control group; B: PCL-PEG group; C: HAAM group; D: PCL-PEG-HAAM group; 21 days after osteogenic induction, Alizarin red staining showed that the PCL-PEG-HAAM group had the largest area and the most distributed red mineralized nodules, followed by the HAAM group and the PCL-PEG group. The control group had the shallowest staining depth and the smallest staining area.

[0108] 7. Western blot detection of osteogenesis-related protein expression: Figure 8 and Fig. 9 The results showed that compared with the control group, the expression levels of osteoblast-related proteins ALP, COL1, and RUNX2 in each group increased, among which the expression levels of RUNX2, COL1, and ALP in the PCL-PEG-HAAM group were the highest, and significantly higher than those in the blank control group and the PCL-PEG group (P<0.05); among them, the expression level of ALP protein in the PCL-PEG-HAAM group was significantly higher than that in the PCL-PEG group (P<0.05), and slightly lower than that in the HAAM group, but there was no statistical difference.

[0109] In summary, the embodiments of the present invention provide a PCL-PEG-HAAM composite scaffold for promoting the differentiation of periodontal ligament stem cells into bones and a preparation method thereof. For the first time, HAAM and PCL-PEG electrospun nanofiber membranes are combined to prepare a PCL-PEG-HAAM composite scaffold, which achieves the complementary advantages and disadvantages of HAAM and PCL-PEG electrospun nanofiber membranes and solves the shortcomings of a single HAAM or a single PCL-PEG electrospun nanofiber membrane.

[0110] Various embodiments of the present invention may be presented in the form of a range; it should be understood that the description in the form of a range is only for convenience and brevity, and should not be understood as a rigid limitation on the scope of the present invention; therefore, the range description should be considered to have specifically disclosed all possible sub-ranges and single numerical values ​​within the range. For example, the range description from 1 to 6 should be considered to have specifically disclosed sub-ranges, such as from 1 to 3, from 1 to 4, from 1 to 5, from 2 to 4, from 2 to 6, from 3 to 6, etc., as well as single numbers within the range, such as 1, 2, 3, 4, 5 and 6, which apply regardless of the range. In addition, whenever a numerical range is indicated herein, it is meant to include any cited number (fractional or integer) within the indicated range.

[0111] The foregoing is merely a specific embodiment of the present invention, which enables those skilled in the art to understand or implement the present invention. Various modifications to these embodiments will be apparent to those skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the present invention. Therefore, the present invention will not be limited to the embodiments shown herein, but rather to the widest scope consistent with the principles and novel features claimed herein.

Claims

1. A method for preparing a PCL-PEG-HAAM composite scaffold for promoting the differentiation of periodontal ligament stem cells into bone, characterized in that: The preparation method comprises the following steps: Freeze-dried HAAM was obtained; The PCL-PEG electrospun nanofiber membrane was obtained; Coating gelatin on the surface of the PCL-PEG electrospun nanofiber membrane to obtain a first PCL-PEG electrospun nanofiber membrane; The freeze-dried HAAM is spread on the surface of the first PCL-PEG electrospun nanofiber membrane and then compacted to obtain the PCL-PEG-HAAM composite scaffold.

2. The method for preparing a PCL-PEG-HAAM composite scaffold for promoting osteogenic differentiation of periodontal ligament stem cells according to claim 1, characterized in that: In terms of weight percentage, the coating amount of the gelatin accounts for 0.1% of the weight of the PCL-PEG electrospun nanofiber membrane.

3. The method for preparing a PCL-PEG-HAAM composite scaffold for promoting osteogenic differentiation of periodontal ligament stem cells according to claim 1, characterized in that: The PCL-PEG electrospun nanofiber membrane and the HAAM have the same size; the size is 4 cm×4 cm.

4. The method for preparing a PCL-PEG-HAAM composite scaffold for promoting osteogenic differentiation of periodontal ligament stem cells according to claim 1, characterized in that: The compaction process is as follows: use a roller to apply pressure to tightly adhere PCL-PEG and HAAM together, remove air bubbles between the two, and place them in a clean room to dry overnight.

5. The method for preparing the PCL-PEG-HAAM composite scaffold for promoting the differentiation of periodontal ligament stem cells into bone according to claim 1, characterized in that: The steps of obtaining freeze-dried HAAM include the following process: Get HAM; The HAM was rinsed with PBS, and then immersed in PBS containing 2wt% of the triple antibody for 30 minutes, and the fresh HAM was placed in a 50mL centrifuge tube containing 5wt% Triton X-100 solution, and the added 5wt% Triton X-100 solution was twice the volume of the tissue, and the HAM was placed in an air bath constant temperature water bath at 37°C for 1 hour of shaking, and then rinsed with PBS solution for 4-5 times after being taken out, and then added to a centrifuge tube containing 0.25wt% trypsin, and placed in an air bath constant temperature water bath at 37°C for 1 hour of shaking, and the volume of trypsin was twice the volume of the tissue, and then rinsed with PBS solution for 4-5 times after being taken out, and then the amniotic epithelial surface was gently scraped with a cell scraper, and then rinsed with PBS solution for 4-5 times after scraping to remove residual cells to obtain the HAAM; The HAAM was placed in a sterile curved dish for trimming, with the amniotic epithelial layer facing upward, and placed in a 10 cm culture dish, placed in a -80°C refrigerator overnight, and freeze-dried on the second day for 8 hours to obtain the freeze-dried HAAM.

6. The method for preparing the PCL-PEG-HAAM composite scaffold for promoting the differentiation of periodontal ligament stem cells into bone according to claim 1, characterized in that: The step of obtaining the PCL-PEG electrospinning nanofiber membrane comprises the following process: Electrospinning nanofibers were prepared using an electrospinning machine. 0.9 g PCL and 0.1 g PEG were weighed on a balance and poured into 8 mL of a solvent consisting of alcohol and hexafluoroisopropanol in a volume ratio of 1:

4. The solvent was placed on a magnetic stirrer and stirred for 16 h at room temperature. The syringe was then completely sucked into a 10 mL syringe and fixed on the electrospinning machine. The receiving distance was set to 20 cm, the voltage to 7 kV, and the propulsion speed to 0.8 mL / h. The syringe was collected on aluminum foil to obtain a PCL-PEG electrospun nanofiber membrane. The fiber membrane was placed in a 37 °C oven and dried for 48 hours to remove the solvent and stored for later use.

7. The method for preparing a PCL-PEG-HAAM composite scaffold for promoting periodontal ligament stem cell differentiation into bone according to claim 1, characterized in that: The thickness of the PCL-PEG electrospinning nanofiber membrane is 140-160 μm.

8. The method for preparing the PCL-PEG-HAAM composite scaffold for promoting the differentiation of periodontal ligament stem cells into bone according to claim 1, characterized in that: The thickness of the HAAM is 35-50 μm.

9. A PCL-PEG-HAAM composite scaffold for promoting the differentiation of periodontal ligament stem cells into bone, characterized in that: The PCL-PEG-HAAM composite scaffold for promoting the differentiation of periodontal ligament stem cells into bone is prepared by the preparation method described in any one of claims 1 to 8.